Palnat 125 mg capsules contain palbociclib, a targeted CDK4/6 inhibitor used to treat advanced hormone receptor-positive, HER2-negative breast cancer. The standard adult dosage is 125 mg taken orally once daily for 21 consecutive days followed by 7 days off, forming a 28-day cycle. Capsules must be swallowed whole with food.

• Very secured payment methods
• Shipping will be calculated on checkout
• Please note that price may increase due to exchange rate, ensure updated price before making payment.